Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell Arteritis
Gary S. Hoffman1,2,3,4,5,6,7, María C. Cid1,2,3,4,5,6,7, Karen E. Rendt-Zagar1,2,3,4,5,6,7, Peter A. Merkel1,2,3,4,5,6,7, Cornelia M. Weyand1,2,3,4,5,6,7, John H. Stone1,2,3,4,5,6,7, Carlo Salvarani1,2,3,4,5,6,7, Weichun Xu1,2,3,4,5,6,7, Sudha Visvanathan1,2,3,4,5,6,7, Mahboob U. Rahman1,2,3,4,5,6,7
1Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
2Boston University School of Medicine, Boston, Massachusetts
3Centocor Research and Development, Inc., Malvern, Pennsylvania
4Emory University School of Medicine, Atlanta, Georgia
5From The Cleveland Clinic Foundation, Cleveland, Ohio
6From The Cleveland Clinic Foundation, Cleveland, Ohio; Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomediques August Pi y Sunyer, Barcelona, Spain; Boston University School of Medicine, Boston, Massachusetts; Emory University School of Medicine, Atlanta, Georgia; Johns Hopkins University School of Medicine, Baltimore, Maryland; Arcispedale Santa Maria Nuova, Reggio Emilia, Italy; and Centocor Research and Development, Inc., Malvern, Pennsylvania.
7Johns Hopkins University School of Medicine, Baltimore, Maryland
Tóm tắt
Từ khóa
Tài liệu tham khảo
Thông tin
Thông tin xuất bản
Annals of Internal Medicine
Tập 146 Số 9
621
Thông tin tác giả